Plasma YKL-40 is elevated, compared to normal levels, in patients with diseases hallmarked by chronic low-grade inflammation; cardiovascular diseases [24-26], cancer [27], liver fibrosis, inflammatory bowel disease and rheumatoid arthritis [28]. This evidence concerns the gene CHI3L1 and rheumatoid arthritis.